Semaglutide main chain P29 Arg34GLP-1(9-37) 1169630-82-3

Details:

Product Information   

Items	Specifications
Product Name	Semaglutide main chain P29 Lyophilized powder
CAS	1169630-82-3
Purity	>98.0%
Application	The production of Semaglutide
Appearance	White Lyophilized powder
Storage	Sealed, Protect from light, Store at - 25°C to -15°C
Specification:	10g, 100g, 1kg, 5kg, 10kg

 

Semaglutide Introduction  

Semaglutide for the use of weight loss

Semaglutide was approved by FDA for the use of weight loss in June 2021. Semaglutide is a long-acting GLP-1 receptor agonist (GLP-1RA) administered once a week.

5 ways Semaglutide promotes weight loss

1. Appetite regulation

• Semaglutide mimics the natural hormone GLP-1, which is produced in the gut and plays a key role in regulating appetite and food intake. GLP-1 receptors are found in the brain, particularly in the hypothalamus and brainstem, which are involved in controlling hunger and satiety. By activating the GLP-1 receptors in the brain, semaglutide helps reduce feelings of hunger, leading to decreased calorie intake.

2. Glucagon suppression

Glucagon is a hormone that is produced by the pancreas and plays a key role in regulating blood sugar levels by stimulating the liver to release glucose into the bloodstream. When semaglutide is administered, it works by binding to GLP-1 receptors in the pancreas, which leads to the suppression of the release of glucagon. By suppressing the release of glucagon, semaglutide helps to lower blood sugar levels in individuals with diabetes.

3. Glucose-dependent insulin secretion

Semaglutide enhances the secretion of insulin in a glucose-dependent manner, meaning it increases insulin release only when blood glucose levels are elevated. This helps to improve blood sugar levels and reduce the risk of hypoglycemia (low blood sugar).

4. Energy expenditure and lipid metabolism

Semaglutide has been shown to increase energy expenditure and promote fat burning, leading to reductions in body weight and improvements in body composition. It may also have a positive impact on lipid metabolism, contributing to favorable changes in cholesterol and triglyceride levels.

5. Delayed gastric emptying

Semaglutide slows down the rate at which food leaves the stomach and enters the small intestine, a process known as delayed gastric emptying. This delayed gastric emptying leads to a prolonged sense of fullness and satiety, further reducing food intake.

 

Company Introduction  

Our factory is located in Nantong, Jiangsu, China. 

Technology: Specialized in bio-synthesized peptide

Business: Provides Drug Peptide Product and CMC Service for Drug Peptide

Team: well-known GMP experts and class-leading scientists

Facility: 3,300m² R&D center, 6,700m² workshop and a 20,000m² manufacturing facility

Objective: Redefining the peptide industry through technological innovation and industrialization

Product Pictures  

Product is airsealed in a bottle, or a LDPE bag first, the label on the bag is optional.

The bottle or LDPE bag is then sealed in an aluminum foil bag to avoid lights, the label on the bag is also optional.